Guangzhou Vesber Biotechnology Co., Ltd. was established in 2007 and is located in Guangdong Medical Valley, a high-tech enterprise park in Nansha District of Guangzhou, near the Guangdong-Hong Kong-Macao Greater Bay Area. In 2011, he won the second prize of the Science and Technology Innovation Competition held by the China Technology Entrepreneurship Association. In 2012, he won the title of Outstanding Innovative Enterprise in the Guangzhou Private Science and Technology Park. In 2013, he was shortlisted in the China Innovation and Entrepreneurship Competition and Guangdong “Pearl Angel Cup” (Growing Enterprise Group) Top 100 enterprise. Won the title of the first batch of high-tech enterprises in Guangdong Province in 2017. It has been supported by a series of government funds such as the National 863 Project, the 12th Five-Year Support Plan, the SME Innovation Fund, the Guangdong Provincial Industry-University-Research Institute, and the Guangzhou Science and Technology Program. It has 22 patents in the United States, Australia, and China.
The company has a 10,000-level clean workshop of 400 square meters and has obtained Class III medical device production license and sales license. The company mainly develops, produces and sells high-level ophthalmic medical products, with a rich product chain, and the representative products are Class III medical devices-Foldable Capsular Vitreous Body (which has obtained the European CE registration certificate and passed the approval of the State Food and Drug Administration) and Class II The medical device-the tear tube resistance core (which has obtained the European CE registration certificate and the domestic medical device registration certificate) has received investment from Yueke Financial Group, the state-owned enterprise Keide Company and the listed OPCOM. The company is now entering a period of rapid development, and sincerely invites people with lofty career plans to join to create life value.